C. Bennett Frank's most recent trade in Ionis Pharmaceuticals Inc was a trade of 261 Common Stock done at an average price of $48.9 . Disclosure was reported to the exchange on Feb. 27, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Other type of transaction at price $ 48.87 per share. | 27 Feb 2026 | 261 | 100,554 (0%) | 0% | 48.9 | 12,754 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2026 | 48,626 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 83.03 per share. | 02 Feb 2026 | 48,626 | 80,293 (0%) | 0% | 83.0 | 4,037,339 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 60.89 per share. | 02 Feb 2026 | 48,626 | 128,919 (0%) | 0% | 60.9 | 2,960,837 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 82.60 per share. | 02 Feb 2026 | 20,000 | 80,293 (0%) | 0% | 82.6 | 1,651,980 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2026 | 16,463 | 2,406 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 83.03 per share. | 02 Feb 2026 | 16,463 | 80,293 (0%) | 0% | 83.0 | 1,366,897 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.60 per share. | 02 Feb 2026 | 16,463 | 96,756 (0%) | 0% | 32.6 | 536,694 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2026 | 11,421 | 106,178 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 82.95 per share. | 29 Jan 2026 | 5,885 | 100,293 (0%) | 0% | 82.9 | 488,141 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2026 | 25,800 | 89,282 | - | - | Performance Restricted Stock Units | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2026 | 21,055 | 103,734 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2026 | 21,055 | 17,434 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2026 | 9,675 | 27,109 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 75.15 per share. | 15 Jan 2026 | 8,977 | 94,757 (0%) | 0% | 75.2 | 674,622 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 19,350 | 19,350 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 59.60 per share. | 05 Sep 2025 | 6,000 | 82,679 (0%) | 0% | 59.6 | 357,581 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.77 per share. | 02 Sep 2025 | 46,800 | 135,479 (0%) | 0% | 53.8 | 2,516,436 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2025 | 46,800 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 60.62 per share. | 02 Sep 2025 | 33,909 | 101,570 (0%) | 0% | 60.6 | 2,055,564 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 61.50 per share. | 02 Sep 2025 | 12,891 | 88,679 (0%) | 0% | 61.5 | 792,797 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 49.14 per share. | 02 Sep 2025 | 5,000 | 88,679 (0%) | 0% | 49.1 | 245,700 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Other type of transaction at price $ 27.71 per share. | 29 Aug 2025 | 213 | 93,679 (0%) | 0% | 27.7 | 5,902 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.60 per share. | 18 Aug 2025 | 10,000 | 103,466 (0%) | 0% | 32.6 | 326,000 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2025 | 10,000 | 18,869 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 43.98 per share. | 18 Aug 2025 | 10,000 | 93,466 (0%) | 0% | 44.0 | 439,776 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Other type of transaction at price $ 28.21 per share. | 28 Feb 2025 | 320 | 93,466 (0%) | 0% | 28.2 | 9,028 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 3,607 | 94,473 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 32.46 per share. | 30 Jan 2025 | 1,327 | 93,146 (0%) | 0% | 32.5 | 43,079 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 33,000 | 56,500 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 22,000 | 63,482 | - | - | Performance Restricted Stock Units | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 18,011 | 97,618 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 18,011 | 38,489 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 32.90 per share. | 15 Jan 2025 | 6,752 | 90,866 (0%) | 0% | 32.9 | 222,114 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 22,000 | 22,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Other type of transaction at price $ 38.64 per share. | 30 Aug 2024 | 177 | 79,607 (0%) | 0% | 38.6 | 6,839 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | Officer Level 14 | Other type of transaction at price $ 34.43 per share. | 29 Feb 2024 | 383 | 79,462 (0%) | 0% | 34.4 | 13,185 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 49.52 per share. | 02 Feb 2024 | 1,885 | 79,047 (0%) | 0% | 49.5 | 93,337 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 3,609 | 80,932 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | C. Bennett Frank | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 49.52 per share. | 01 Feb 2024 | 1,853 | 79,079 (0%) | 0% | 49.5 | 91,752 | Common Stock |
| Ionis Pharma Inc | C. Bennett Frank | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2024 | 18,314 | 23,500 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | C. Bennett Frank | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2024 | 18,314 | 84,068 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | C. Bennett Frank | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 50.42 per share. | 16 Jan 2024 | 6,745 | 77,323 (0%) | 0% | 50.4 | 340,063 | Common Stock |
| Ionis Pharma Inc | Bennett C. Frank | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 20,400 | 41,814 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 17,000 | 41,482 | - | - | Performance Restricted Stock Units | |
| Ionis Pharma Inc | C. Bennett Frank | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 27,200 | 27,200 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Frank Bennett C. | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2023 | 16,113 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Frank C. Bennett | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 47.34 per share. | 20 Dec 2023 | 16,113 | 81,867 (0%) | 0% | 47.3 | 762,789 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 49.29 per share. | 20 Dec 2023 | 16,113 | 65,754 (0%) | 0% | 49.3 | 794,211 | Common Stock |
| Ionis Pharma Inc | C. Bennett Frank | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 47.34 per share. | 20 Dec 2023 | 6,500 | 72,254 (0%) | 0% | 47.3 | 307,710 | Common Stock |
| Ionis Pharma Inc | Bennett Frank C. | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2023 | 6,500 | 16,113 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Frank C. Bennett | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 49.64 per share. | 20 Dec 2023 | 6,500 | 65,754 (0%) | 0% | 49.6 | 322,643 | Common Stock |
| Ionis Pharma Inc | C. Bennett Frank | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 14,002 | 31,223 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Bennett Frank C. | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 49.21 per share. | 14 Dec 2023 | 14,002 | 65,754 (0%) | 0% | 49.2 | 689,085 | Common Stock |
| Ionis Pharma Inc | Bennett Frank C. | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 47.34 per share. | 14 Dec 2023 | 14,002 | 79,756 (0%) | 0% | 47.3 | 662,855 | Common Stock |
| Ionis Pharma Inc | C. Bennett Frank | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 50.19 per share. | 14 Dec 2023 | 8,610 | 65,754 (0%) | 0% | 50.2 | 432,110 | Common Stock |
| Ionis Pharma Inc | Bennett C. Frank | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 8,610 | 22,613 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Frank C. Bennett | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 47.34 per share. | 14 Dec 2023 | 8,610 | 74,364 (0%) | 0% | 47.3 | 407,597 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Other type of transaction at price $ 30.51 per share. | 28 Feb 2023 | 383 | 70,034 (0%) | 0% | 30.5 | 11,687 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 3,609 | 71,464 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 40.57 per share. | 03 Feb 2023 | 1,813 | 69,651 (0%) | 0% | 40.6 | 73,560 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 19,417 | 21,414 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 19,417 | 74,833 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 38.89 per share. | 17 Jan 2023 | 6,978 | 67,855 (0%) | 0% | 38.9 | 271,356 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2023 | 16,387 | 40,831 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2023 | 13,656 | 24,482 | - | - | Performance Restricted Stock Units | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 21,849 | 21,849 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Other type of transaction at price $ 28.97 per share. | 31 Aug 2022 | 183 | 55,416 (0%) | 0% | 29.0 | 5,301 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Other type of transaction at price $ 28.37 per share. | 28 Feb 2022 | 346 | 55,233 (0%) | 0% | 28.4 | 9,817 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2022 | 18,842 | 24,444 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2022 | 18,842 | 61,613 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.12 per share. | 18 Jan 2022 | 6,726 | 54,887 (0%) | 0% | 30.1 | 202,587 | Common Stock |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 14,435 | 43,286 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 10,826 | 10,826 | - | - | Performance Restricted Stock Units | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 28,869 | 28,869 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | C. Frank Bennett | EVP & Chief Scientific Officer | Other type of transaction at price $ 33.79 per share. | 31 Aug 2021 | 151 | 42,771 (0%) | 0% | 33.8 | 5,103 | Common Stock |